| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $365K | — |
| R&D Expense | $10.6M | +96.6% |
| SG&A Expense | $4.1M | +63.1% |
| Operating Income | -$17.3M | -62.7% |
| Pre-tax Income | -$13.7M | -0.4% |
| Income Tax | $0 | — |
| Net Income | -$13.7M | -0.4% |
| EPS (Basic) | -$0.61 | +57.0% |
| EPS (Diluted) | -$0.61 | +57.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.6M | +29.8% |
| Accounts Receivable | $365K | — |
| Current Assets | $14.6M | +29.9% |
| Total Assets | $16.6M | +21.1% |
| Current Liabilities | $2.8M | -68.9% |
| Total Liabilities | $3.2M | -66.6% |
| Stockholders' Equity | $13.4M | +222.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.5M | -60.8% |
| Investing Cash Flow | -$65K | +73.1% |
| Financing Cash Flow | $16.7M | +23.1% |